All In Biotech

Drug Trial Radar · NCT06405633

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD

A Phase 1b/2a Open-label Single Ascending Doses (SAD) and Multiple Ascending Doses (MAD) Research Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Participants With AATD Pi*ZZ on WVE-006 (RestorAATion-2)

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Jul 19, 2024

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Wave Life Sciences USA, Inc.Industry
Sponsor type
Industry
First posted
May 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this open-label study is to assess the safety, tolerability, pharmacodynamics, and pharmacokinetics of WVE-006 in participants with alpha-1 antitrypsin deficiency (AATD) following Period 1 single ascending dose (SAD) and Period 2 multiple ascending doses (MAD), respectively.

Conditions

  • Alpha-1 Antitrypsin Deficiency

Interventions

  • WVE-006Drug

    RNA editing oligonucleotide

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of participants with adverse eventsTime frame: Up to 36 Weeks

Locations

9 sites in 6 countries. Site status is shown where the registry gives one.

  • St. Vincent's Hospital, Melbourne

    Fitzroy, Victoria, Australia · Recruiting

  • Dalhousie University - Queen Elizabeth II Health Sciences Centre

    Halifax, Nova Scotia, Canada · Recruiting

  • Inspiration Research Limited

    Toronto, Ontario, Canada · Recruiting

  • Turku University Hospital

    Turku, Finland · Active not recruiting

  • Universitaetsklinikum Aachen, AoeR

    Aachen, Germany · Active not recruiting

  • Waikato Hospital

    Hamilton, New Zealand · Recruiting

  • Queen Elizabeth Hospital, University Hospital Birmingham

    Birmingham, United Kingdom · Active not recruiting

  • Cambridge University - Addenbrooke's Hospital

    Cambridge, United Kingdom · Active not recruiting

  • Royal Free London NHS Foundation Trust

    London, United Kingdom · Active not recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.